Global Virtual Biopsy Market is valued at USD 0.8 Billion in 2024 and is predicted to reach USD 2.1 Billion by the year 2034 at a 12.3% CAGR during the forecast period for 2025-2034.
A virtual biopsy is a non-invasive diagnostic method that offers a safer substitute for conventional tissue biopsy methods by examining tissue properties and identifying anomalies using cutting-edge imaging technology, such as MRI or CT scans, in conjunction with molecular analysis. Several factors are contributing to the significant rise of the virtual biopsy market. The necessity for early and precise diagnostic techniques has been brought to light by the rising incidence of cancer and other chronic illnesses. Furthermore, non-invasive techniques that provide less discomfort and faster recovery are becoming increasingly popular. Moreover, diagnostic accuracy has increased due to developments in imaging technology. Additionally, expanding healthcare spending and better infrastructure, particularly in emerging nations, are opening up access to virtual biopsy and fostering market growth in the coming years.
However, the high price of sophisticated diagnostic tools and technologies and the lack of trained professionals, which restricts accessibility, particularly in underdeveloped areas, are factors that may limit the growth of the target market during the forecast period. Furthermore, virtual biopsy techniques provide accurate, non-invasive diagnostics, and their use is growing among patients and healthcare professionals. Furthermore, early identification, treatment planning, and patient outcomes are improved when these technologies are incorporated into oncology research and clinical procedures, which is the global virtual biopsy market over the forecast period.
The virtual biopsy market is segmented based on therapeutic area, type of cancer, type of imaging technology, and end-user. Based on the therapeutic area, the market is segmented into oncological disorders, neurological disorders, cardiovascular disorders, ophthalmological disorders, endocrine disorders, gastrointestinal disorders, and others. By type of cancer, the market is segmented into solid malignancies, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. By type of imaging technology, the market is segmented into magnetic resonance imaging, computed tomography, X-ray, and ultrasound. The market is segmented by end-users into hospitals and clinics, research institutes, diagnostic centres, and others.
The oncological disorders category will hold a major share of the global virtual biopsy market in 2023. This is attributed to the increasing incidence of cancer and the need for non-invasive diagnostic methods. Additionally, unlike traditional invasive methods like tissue biopsies, virtual biopsy enables accurate tumour surveillance and early identification. Moreover, its widespread acceptance is fueled by the ability to quickly evaluate molecular and cellular data utilizing improved imaging and imaging-guided technologies, which provides substantial benefits in cancer diagnosis and therapy planning.
The breast cancer segment is projected to grow at a rapid rate in the global virtual biopsy market because breast cancer is becoming more commonplace globally, and there is a rising need for non-invasive diagnostic options. Virtual biopsy provides a quicker and less invasive alternative to traditional tissue biopsies by enabling precise cancer diagnosis and surveillance. Additionally, virtual biopsies can offer comprehensive insights into cancer features due to developments in imaging technologies and genetic analysis. Moreover, this is essential for early-stage breast cancer detection and individualized therapy planning, which supports market growth, especially in countries such as the US, Germany, the UK, China, and India.
The North American virtual biopsy market is expected to register the largest market share in terms of revenue shortly. This can be attributed to an extensive healthcare system, widespread use of cutting-edge diagnostic tools, and an increasing need for non-invasive cancer screening techniques. Leading biotechnology and healthcare firms are also present, contributing to the expansion of virtual biopsy solutions in the area. In addition, Asia Pacific is projected to grow rapidly in the global virtual biopsy market because of increasing awareness of non-invasive diagnostic techniques, rising cancer prevalence, and improved healthcare infrastructure. Furthermore, the region’s robust market expansion is also attributed to the adoption of cutting-edge medical technology and increasing healthcare investments in nations like China and India are also driving the region's growth.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 0.8 Billion |
|
Revenue Forecast In 2034 |
USD 2.1 Billion |
|
Growth Rate CAGR |
CAGR of 12.3% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Therapeutic Area, Type Of Cancer, Type Of Imaging Technology, And End-user |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
GE Healthcare, Imaging Biometrics, OptoVibronex, ImageBiopsy Lab, Median Technologies, Quibim, Siemens Healthineers, City Imaging and Clinical Labs. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Virtual Biopsy Market Snapshot
Chapter 4. Global Virtual Biopsy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Virtual Biopsy Market Industry Trends
4.10. Global Virtual Biopsy Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Virtual Biopsy Market Segmentation 1: By Type of Target Therapeutic Area, Estimates & Trend Analysis
5.1. Market Share by Type of Target Therapeutic Area, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Target Therapeutic Area:
5.2.1. Oncological Disorders
5.2.2. Neurological Disorders
5.2.3. Cardiovascular Disorders
5.2.4. Ophthalmological Disorders
5.2.5. Endocrine Disorders
5.2.6. Gastrointestinal Disorders
5.2.7. Others
Chapter 6. Virtual Biopsy Market Segmentation 2: By Type of Cancer Targeted, Estimates & Trend Analysis
6.1. Market Share by Type of Cancer Targeted, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Cancer Targeted:
6.2.1. Solid Malignancies
6.2.2. Breast Cancer
6.2.3. Lung Cancer
6.2.4. Prostate Cancer
6.2.5. Colorectal Cancer
6.2.6. Brain Cancer
6.2.7. Others
Chapter 7. Virtual Biopsy Market Segmentation 3: By Type of Imaging Technology, Estimates & Trend Analysis
7.1. Market Share by Type of Imaging Technology, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Imaging Technology:
7.2.1. Magnetic Resonance Imaging
7.2.2. Computed Tomography
7.2.3. X-ray
7.2.4. Ultrasound
7.2.5. Others
Chapter 8. Virtual Biopsy Market Segmentation 4: By End Users, Estimates & Trend Analysis
8.1. Market Share by End Users, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Users:
8.2.1. Hospitals and Clinics
8.2.2. Research Institutions and Diagnostic Centers
8.2.3. Others
Chapter 9. Virtual Biopsy Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Virtual Biopsy Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.2.3. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.2.4. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.2.5. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.3. Europe
9.3.1. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.3.3. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.3.4. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.3.5. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.4.3. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.4.4. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.4.5. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.5. Latin America
9.5.1. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.5.3. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.5.4. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.5.5. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.6.3. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.6.4. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.6.5. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. GE Healthcare
10.2.1.1. Business Overview
10.2.1.2. Key Type of Target Therapeutic Area/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Imaging Biometrics
10.2.3. OptoVibronex
10.2.4. ImageBiopsy Lab
10.2.5. Median Technologies
10.2.6. Quibim
10.2.7. Siemens Healthineers
10.2.8. City Imaging and Clinical Labs
Segmentation of Virtual Biopsy Market-
By Type of Therapeutic Area-
By Type of Cancer-
By Type of Imaging Technology-
By End-User-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
